Search results
Results From The WOW.Com Content Network
Gambro is a global medical technology company that manufactures products for dialysis treatment. The company is involved in developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy [ clarify ] , and other extracorporeal therapies for chronic and acute patients.
Credit: News Øresund – Johan Wessman. Alf Erik Holger Crafoord (né Lundquist; 25 July 1908 – 21 May 1982) [1] was a Swedish industrialist and patron. He founded Gambro, which developed and commercialised the artificial kidney. He also established the Crafoord Foundation , the proceeds of which fund the Crafoord Prize for scientific research.
Gambro opened its first dialysis clinic in Lund in 1991. The clinic activities expanded under the name Gambro Healthcare and by 2005 the company managed 150 dialysis clinics worldwide. Gambro Healthcare was divested from Gambro in 2007 and taken over by Bridgepoint Capital, a major private healthcare investor in Europe, and the company ...
Regardless of the format, there's likely a scam to be had. Scams and fraud can come in the forms of phone calls, online links, door-to-door sales and mail. Below are common scams the New Jersey ...
Baxter International (NYS: BAX) announced today that it has agreed to buy privately held dialysis systems maker Gambro AB for approximately $4 billion in total consideration. In a statement ...
List of United States dialysis providers: Abramson Center for Jewish Life; American Renal Associates; American Renal Care; Atlantic Dialysis Management; BMA (BioMedical Applications) Centers for Dialysis Care; Concerto Renal Services; DaVita Inc. Diversified Specialty Institute Holdings, Inc. Dialysis Clinic, Inc; Evergreen Nephrology ...
Memory-boosting supplement Prevagen is a scam, regulators say. Vocativ. Ed Cara. February 10, 2017 at 12:46 PM. ... In Other News. Entertainment. Entertainment. Entertainment Weekly
Dialysis Clinic, Inc. is a nonprofit medical corporation founded in 1971 and chartered as a 501(c)(3) tax-exempt organization under IRS regulations. It was founded for care and research of patients with kidney disease and supports activities in kidney transplant and dialysis across the US.